The Scientist

» bioluminescence and disease/medicine

Most Recent

Jazz Pharmaceuticals is set to purchase Celator to acquire an experimental treatment for acute myeloid leukemia.

1 Comment

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

1 Comment

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Genetic Connections Among Human Traits

Genetic Connections Among Human Traits

By | May 16, 2016

A study identifies genetic variants that are linked to multiple phenotypes.

0 Comments

image: Sea Star Comeback?

Sea Star Comeback?

By | May 9, 2016

Hordes of baby sea stars on the Pacific coast survived the summer and winter of 2015—promising news about populations that have been devastated by a wasting disease.

0 Comments

image: Breast Milk Primes Gut for Microbes

Breast Milk Primes Gut for Microbes

By | May 5, 2016

Maternal antibodies engender a receptive gut environment for beneficial bacteria in newborn mice.

2 Comments

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Contributors

Contributors

By and | May 1, 2016

Meet some of the people featured in the May 2016 issue of The Scientist.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham